Thrivent Financial for Lutherans’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
|
|||||
|
2025
Q1 | $1.51M | Sell |
|
|||||
|
2024
Q4 | $1.62M | Buy |
|
|||||
|
2024
Q3 | $1.51M | Buy |
|
|||||
|
2024
Q2 | $1.24M | Sell |
|
|||||
|
2024
Q1 | $1.1M | Sell |
|
|||||
|
2023
Q4 | $1.1M | Sell |
|
|||||
|
2023
Q3 | $943K | Sell |
|
|||||
|
2023
Q2 | $1.19M | Sell |
|
|||||
|
2023
Q1 | $1.24M | Buy |
|
|||||
|
2022
Q4 | $1.1M | Sell |
|
|||||
|
2022
Q3 | $1.43M | Buy |
|
|||||
|
2022
Q2 | $1.48M | Buy |
|
|||||
|
2022
Q1 | $1.53M | Buy |
|
|||||
|
2021
Q4 | $2.1M | Buy |
|
|||||
|
2021
Q3 | $1.88M | Buy |
|
|||||
|
2021
Q2 | $580K | Buy |
|
|||||
|
2021
Q1 | $673K | Sell |
|
|||||
|
2020
Q4 | $5.89M | Buy |
|
|||||
|
2020
Q3 | $5.61M | Sell |
|
|||||
|
2020
Q2 | $6.77M | Sell |
|
|||||
|
2020
Q1 | $7.97M | Sell |
|
|||||
|
2019
Q4 | $55.1M | Buy |
|
|||||
|
2019
Q3 | $44.5M | Buy |
|
|||||
|
2019
Q2 | $49.5M | Buy |
|
|||||
|
2019
Q1 | $53.6M | Buy |
|
|||||
|
2018
Q4 | $37.9M | Buy |
|
|||||
|
2018
Q3 | $3.95M | Sell |
|
|||||
|
2018
Q2 | $3.03M | Buy |
|
|||||
|
2018
Q1 | $2.35M | Buy |
|
|||||
|
2017
Q4 | $1.79M | Buy |
|
|||||
|
2017
Q3 | $1.75M | Buy |
|
|||||
|
2017
Q2 | $1.39M | Buy |
|
|||||
|
2017
Q1 | $1.13M | Buy |
|
|||||
|
2016
Q4 | $1.04M | Buy |
|
|||||
|
2016
Q3 | $989K | Buy |
|
|||||
|
2016
Q2 | $1.1M | Buy |
|
|||||
|
2016
Q1 | $862K | Buy |
|
|||||
|
2015
Q4 | $841K | Buy |
|
|||||
|
2015
Q3 | $651K | Buy |
|
|||||
|
2015
Q2 | $701K | Buy |
|
|||||
|
2015
Q1 | $513K | Hold |
|
|||||
|
2014
Q4 | $354K | Sell |
|
|||||
|
2014
Q3 | $324K | Sell |
|
|||||
|
2014
Q2 | $473K | Buy |
|
|||||
|
2014
Q1 | $505K | Buy |
|
|||||
|
2013
Q4 | $389K | Buy |
|